As summer begins,all things flourish,and two major international academic conferences are on the horizon.One of the world's premier clinical oncology events,the 2024 American Society of Clinical Oncology(ASCO) Annual Meeting,is set to take place from May 31st to June 4th(Central Daylight Time)in Chicago,USA,gathering over 34,000 oncology professionals from around the globe to showcase the latest groundbreaking advancements in cancer research. Immediately following,the 29th Congress of the European Hematology Association(EHA) in 2024 will be held from June 13th to June 16th in Madrid,Spain,where more than 10,000 professionals representing over 100 countries will converge to exchange innovative ideas and clinical research findings in the field of hematology.

Scientific research and clinical practice are the dual engines driving medical advancement,especially in the realm of oncology.Embracing the fast lane of tumor research,innovation,and clinical development,the GoBroad Medical Team consistently focuses on unmet patient needs,relentlessly pursuing breakthroughs in unresolved clinical challenges.At this year's ASCO and EHA annual meetings,the team will proudly present 14 research achievements,spanning from innovative clinical strategies to transformative nursing practices,from the continuous refinement of hematopoietic stem cell transplantation techniques to ongoing optimization of CAR-T therapies.Once again,they are set to share with the world the Chinese experience,Chinese solutions,and Chinese wisdom!

EHA Conference Presentation

Abstract Number: S305

Title: CMV/EBV INFECTIONS IN CAR-T THERAPY FOR RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

Presenter: Jing Pan

Authors: Yue Tan, Zhuojun Ling, Jinlong Xu, Jiajia Duan, Zelin Wang, Kai Wang, Fan Wu, Quangang Wang, Jing Pan

Institution: Beijing GoBroad Hospital

Abstract Number: S339

Title: PREVIOUS-TRANSPLANT OR NEW-MATCH DONOR CD5 CAR T CELLS IN PEDIATRIC AND ADULT RELAPSED/REFRACTORY T-ALL:FIRST-IN-HUMAN,PHASE 1 STUDY

Presenter: Jing Pan

Authors: Jing Pan¹, Yue Tan², Lingling Shan², Biping Deng¹, Zhuojun Ling¹, Jinlong Xu¹, Jiajia Duan¹, Zelin Wang¹, Kai Wang¹, Guang Hu³

Institutions:1 Beijing GoBroad Hospital; 2 State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases,Institute of Hematology and Blood Diseases Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College; 3 Nanjing IASO Bio

ASCO Poster Presentation

Abstract Number: 6518

Title: Phase I study of functionally enhanced CD33 CAR T cells in patients with relapsed or refractory acute myeloid leukemia.

Presenter: Jing Pan

Authors: Jing Pan¹, Shiyu Zuo², Chuang Li², Zhuojun Ling¹, Jinlong Xu¹, Jiajia Duan¹, Zelin Wang¹, Tong Wu³, Xiaoming Feng²

Institutions:1 Beijing GoBroad Hospital;2 State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases,Institute of Hematology and Blood Diseases Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College;3 Beijing GoBroad Boren Hospital

EHA Poster Presentation

Abstract Number: P429

Title: FIVE-YEAR OUTCOME OF CD19 COMBINED WITH CD22 CAR-T CELL THERAPY IN B-ALL PATIENTS RELAPSED AFTER ALLO-TRANSPLANTATION

Authors: Shuangyou Liu, Lihong An, Zhichao Yin, Yuehui Lin, Biping Deng, Xinjian Yu, Qinlong Zheng, Defeng Zhao,Tong Wu, Chunrong Tong

Institution: Beijing GoBroad Boren Hospital

Abstract Number: P1238

Title: Genetic Mutation Spectrum of Childhood T-Lymphoblastic Lymphoma in China and Its Impact on Prognosis

Presenter: Li Yang

Authors: Professor Qinlong Zheng and Professor Yonghong Zhang from Beijing GoBroad Boren Hospital are the corresponding authors.Li Yang from Beijing GoBroad Boren Hospital and Professor Ling Jin from Beijing Children's Hospital,Capital Medical University,are the first authors.

Institutions: Beijing GoBroad Boren Hospital,Beijing Children's Hospital,Capital Medical University,and 15 other hospitals collaborating under CNCL.

Abstract Number: P1304

Title: TBI-ATG-BASED CONDITIONING REGIMEN IMPROVED THE SURVIVAL OF ADULT PATIENTS WITH ADVANCED PERIPHERAL T-CELL LYMPHOMA AFTER HAPLOIDENTCAL ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION

Presenter: Zhao Chuxian

Authors: Zhao Chuxian, Wei Daolin, Liu Huixia, Jiang Ying, Shao Shan, Wang Chun, Zhu Jun

Institution: Shanghai Zhaxin Hospital/Liquan Hospital,GoBroad Medical Institute of Hematology(Shanghai Center)

Abstract Number: P1333

Title: IMPROVED OUTCOMES IN ADOLESCENTS AND ADULTS WITH THALASSAEMIA MAJOR USING MODERN TRANSPLANTATION TECHNIQUES COMBINED WITH IMPROVED PRE-TRANSPLANT CONDITION

Presenter: Jianyun Liao

Authors: Jianyun Liao, Chaoke Bu, Lan He, Jujian He, Weiwei Zhang, Yanfeng Zhou, Bo Lv, Wenqian Shi, Yuanying Zeng, Yuqian Xia, Yuelin He, Chunfu Li

Institution: Nanfang-Chunfu Children's Institute of Hematology,GoBroad Medical Institute of Hematology(Guangdong Center)

Abstract Number: P1356

Title: ANALYSIS OF SAFETY AND EFFICACY OF LUSPATERCEPT AFTER ALLO-HSCT IN PATIENTS WITH HEMATOLOGICAL MALIGANCIES

Presenter: Zhihui Li

Authors: Zhihui Li, Xianxuan Wang, Xiaopei Wen, Jingjing Wang, Yongqiang Zhao, Qian Fei, Yanzhi Song, Teng Xu, Lei Wang, Tong Wu

Institution: Beijing GoBroad Boren Hospital

Abstract Number: P1477

Title: CAR T-CELL THERAPY BRIDGING ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

Presenter: Zhiyong Peng

Authors: Zhiyong Peng, Sa Zong, Haoran Tang, Yanru Pei, Dan Yue, Xia Li

Institution: Nanfang-Chunfu Children’s Institute of Hematology,GoBroad Medical Institute of Hematology(Guangdong Center)

Abstract Number: P2103

Title: VENETOCLAX AND BTK INHIBITORS BASED CHEMOTHERAPY IS A POTENTIAL EFFECTIVE CAR-T BRIDGING THERAPY IN R/R B-NHL

Presenter: Rui Liu

Authors: Rui Liu, Fan Yang, Lixia Ma, Zhonghua Fu, Hui Shi, Yuelu Guo, Shaomei Feng, Peihao Zheng, Fei Xue, Ruiting Li, Miaomiao Cao, Bian Wei, Xiaoyan Ke*, Kai Hu*

Institution: Beijing GoBroad Hospital

EHA Paper Abstract

Abstract Number: PB3039

Title: INCORPORATING RADIATION WITH CAR T-CELL THERAPY DEMONSTRATED A HIGH RATE OF REMISSION IN PATIENTS WITH B CELL LYMPHOMA INVOLVING THE CNS

Presenter: Hui Shi

Authors: Hui Shi, Miaomiao Cao, Yuelu Guo, Fan Yang, Xiaoyan Ke, Kai Hu

Institution: Beijing GoBroad Hospital

Abstract Number: PB3040

Title: NUTRITIONAL STATUS AND INFLUENCING FACTORS ANALYSIS OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES DURING TRANSPLANT COMBINED WITH CAR-T CELL IMMUNOTHERAPY

Presenter: Yabin Wang

Authors: Yabin Wang, Jin Li, Fan Yang, Rui Liu, Xiaoyan Ke, Kai Hu

Institution: Beijing GoBroad Boren Hospital

Abstract Number: PB3131

Title: SHORT-TERM SUBSTITUTION OF CALCINEURIN INHIBTORS(CNIS)WITH RECOMBINANT HUMANIZED ANTI-CD25 MONOCLONAL ANTIBODY(ANTI-CD25 RHMAB)AS AGVHD PROPHYLAXIS IN CNIS INTOLERANT PATIENTS AFTER ALLO-HSCT

Presenter: Shan Shao

Authors: Shan Shao, Huixia Liu, Ying Jiang, Su Li, Daolin Wei, Jun Zhu, Chun Wang, Chuxian Zhao

Institution: Shanghai Zhaxin Hospital/Liquan Hospital,GoBroad Medical Institute of Hematology(Shanghai Center)

Abstract Number: PB3293

Title: EXPLORATION OF THE PRACTICAL DOSE OF LIPOSOMAL AMPHOTERICIN B(L-AMB)IN CHINESE IFD PATIENTS WITH HEMATOLOGIC MALIGNANCIES

Presenter: Panpan Ma

Authors: Panpan Ma, Huixia Liu, Ying Jiang, Daolin Wei, Shan Shao, Su Li, Chuxian Zhao, Chun Wang, Jun Zhu

Institution: Shanghai Zhaxin Hospital/Liquan Hospital,GoBroad Medical Institute of Hematology(Shanghai Center)

Delving into Subtle Research Insights，Resonating with Innovation in the New Era

In step with the pace of societal development,the health demands of the new era are becoming increasingly diverse.Confronted with the pressing treatment needs of patients,the GoBroad Medical Team breaks through traditional therapeutic"ceilings"with innovative thinking,and expands the boundaries of classical approaches through optimized strategies.Devoted to prolonging patients'lives,enhancing quality of existence,and striving for higher rates of clinical cures,they tirelessly work towards improving patient outcomes.

*In the order of abstract numbers